116 related articles for article (PubMed ID: 38530196)
1. Incidental [18F]FDG-avid focuses in parotid glands on PET/CT.
Klug TE; Hillerup S; Dias AH; Gormsen LC; Kristensen PN
Acta Otolaryngol; 2024 Feb; 144(2):147-152. PubMed ID: 38530196
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of parotid gland incidentalomas on (18)F-FDG PET/CT.
Makis W; Ciarallo A; Gotra A
Clin Imaging; 2015; 39(4):667-71. PubMed ID: 25888252
[TBL] [Abstract][Full Text] [Related]
3. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.
Seo YL; Yoon DY; Baek S; Lim KJ; Yun EJ; Cho YK; Bae WJ; Chung EJ; Kwon KH
Eur Radiol; 2015 Jan; 25(1):171-7. PubMed ID: 25182627
[TBL] [Abstract][Full Text] [Related]
4. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management.
Basu S; Houseni M; Alavi A
Nucl Med Commun; 2008 Apr; 29(4):367-73. PubMed ID: 18317302
[TBL] [Abstract][Full Text] [Related]
5. Predictors of pathologic outcome of focal FDG uptake in the parotid gland identified on whole-body FDG PET imaging.
Mabray MC; Behr SC; Naeger DM; Flavell RR; Glastonbury CM
Clin Imaging; 2015; 39(6):1073-9. PubMed ID: 26324219
[TBL] [Abstract][Full Text] [Related]
6. Incidentally found parotid gland lesion in
Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M
BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868
[TBL] [Abstract][Full Text] [Related]
7. Parotid incidentalomas: a systematic review.
Thompson C; Nolli T; Bannister M
J Laryngol Otol; 2021 Sep; 135(9):765-769. PubMed ID: 34308809
[TBL] [Abstract][Full Text] [Related]
8. Frequency and malignancy rate of incidental focal salivary gland lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.
Danstrup CS; Lyhne NM; Kovacsne A; Fisker R; Zacho HD
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):357-364. PubMed ID: 35939059
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT).
Familiar C; Merino S; Valhondo R; López C; Pérez X; De Los Monteros PE; Hernández F; Pazos M; Pallarés R; Pascual AC
Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of conventional whole-body ¹⁸F-FDG PET/CT in the incidental findings of parotid masses.
Wang HC; Zuo CT; Hua FC; Huang ZM; Tan HB; Zhao J; Guan YH
Ann Nucl Med; 2010 Oct; 24(8):571-7. PubMed ID: 20640540
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Significance of Incidental Parotid Uptake in a PET/CT Study: A Diagnostic Algorithm.
Üstün F; Taştekin E; Taş A; Altun GD
Curr Med Imaging Rev; 2019; 15(3):326-333. PubMed ID: 31989884
[TBL] [Abstract][Full Text] [Related]
12. Focal fluorine-18 fluorodeoxyglucose-avid parotid findings in patients with lung cancer: prevalence and characteristics.
Davidson T; Komissar O; Goshen E; Shalmon B; Chikman B; Ben-Nun A; Ben-Haim S
Nucl Med Commun; 2016 Sep; 37(9):969-74. PubMed ID: 27218431
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk of malignancy of focal incidental uptake detected by fluorine-18-fluorodeoxyglucose positron emission tomography in the parotid gland: a meta-analysis.
Treglia G; Bertagna F; Sadeghi R; Muoio B; Giovanella L
Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3617-26. PubMed ID: 25262193
[TBL] [Abstract][Full Text] [Related]
14. Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?
Kendi AT; Magliocca KR; Corey A; Galt JR; Switchenko J; Wadsworth JT; El-Deiry MW; Schuster DM; Saba NF; Hudgins PA
AJR Am J Roentgenol; 2016 Sep; 207(3):635-40. PubMed ID: 27276388
[TBL] [Abstract][Full Text] [Related]
15. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
[TBL] [Abstract][Full Text] [Related]
16. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation.
Hagenimana N; Dallaire J; Vallée É; Belzile M
J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):22. PubMed ID: 28320460
[TBL] [Abstract][Full Text] [Related]
17. Intra-parotid lymph node metastasis in patients with non-cutaneous head and neck cancers: clinical and imaging features for differentiation from simultaneous parotid primary tumor.
Kim HJ; Yoon DY; Hong JH; Yun EJ; Baek S; Kim ES; Park MW; Kwon KH
Acta Radiol; 2020 Dec; 61(12):1628-1635. PubMed ID: 32138522
[TBL] [Abstract][Full Text] [Related]
18. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
Brindle R; Mullan D; Yap BK; Gandhi A
Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
[TBL] [Abstract][Full Text] [Related]
19. Incidental Detection of Synchronous Lung Melanoma on 18F-FDG PET/CT in a Patient With Parotid Gland Myoepithelial Carcinoma.
Parihar AS; Ga A; Sood K; Seam RK; Kaushal V; Sood A; Kakkar N; Mittal BR
Clin Nucl Med; 2018 Apr; 43(4):e127-e129. PubMed ID: 29401144
[TBL] [Abstract][Full Text] [Related]
20.
Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A
J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
